Correction: Preclinical development of 1B7/CD3, a novel anti-TSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL.
Ze TianChunhua ShiGuojun YangJason K AllenQing ShiAmin Al-ShamiJill Wardell OlsonMelinda G SmithQing ChangJasbir KaurJunping YouTimothy E LoftonMichelle A GonzalezQi ZhangDongXing ZhaSarah K TasianNitin JainMarina Y KonoplevaTimothy HeffernanJeffrey J MolldremPublished in: Leukemia (2023)
Keyphrases